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Traditionally, the biological ﬂuorination of complex biological systems like proteins is achieved through
substitution of canonical amino acids or addition of ﬂuorinated amino acids in the context of the standard
genetic code. Ribosomal translation of monoﬂuorinated amino acids into proteins often yields structures
with minimal local changes in the interior but, on the same time, results in large global effects on
characteristic features of the biopolymers (such as dramatically changed activity proﬁle or folding
stability). This is due to the novel and unique local interactions delivered by ﬂuorine atoms such as
(i) increase in the covalent radii (ii) changed polarities; (iii) changed hydrogen bond acceptor ability;
(iv) altered water solubility as well as water ↔ organic solvent energy transfer. On the other hand, the
biological incorporation of tri- or global ﬂuorinated amino acids (such as triﬂuoroleucine, triﬂurovaline,
and their hexaﬂuoro counterparts, ﬂuoromethionine and triﬂuoronorleucine etc.) represents still a
challenge, as the natural structural scaffolds are optimized for hydrocarbon during evolution but not for
ﬂuorocarbon cores. Future work will be focused on the re-design of existing or de novo design of novel
protein scaffolds capable of accommodating such building blocks into functional biologically active
proteins and proteomes in the context of the viable cells.
Introduction
Fluorinated organic compounds and polymers are interesting
target molecules, in biological and medicinal chemistry, material
sciences, agrochemicals and crop sciences. They also possess
unique features highly attractive not only for synthetic appli-
cations but also for the pharmaceutical industry as ﬂuorination
improve the bioavailability of drugs.1,2 This is due to the fact
that the presence of ﬂuorine atoms or ﬂuorinated groups in a par-
ticular molecule is associated with the unusual and unique phys-
icochemical properties, which cannot be achieved by any other
element.1,3
Fluorine is the most abundant halogen in the Earth’s crust.6 It
appears in levels comparable to that of nitrogen; however, only
12 organic compounds are known to occur in nature whereas the
majority of ﬂuorine is contained within inorganic substances.1,2,7
Conversely, synthetic organic chemistry provided us with a large
number of compounds in which hydrogen atoms are partially or
completely replaced by ﬂuorine atoms. High-level or even com-
plete substitution of hydrocarbons, yields ﬂuorocarbons charac-
terized with lower boiling points and water solubility, and an
increased molar volume. On the other hand, many synthetic
ﬂuorine containing organic compounds of anthropogenic origin
are ﬂuorinated to a lesser extent. For example, monoﬂuorinated
analogs of aromatic amino acids have often been used as substi-
tutes in protein biosynthesis.
Certainly, the interest in synthesizing ﬂuorinated biological
molecules such as proteins can be explained by the potent
electronic effects of this halogen, particularly on nearby func-
tional groups. For example, due to ﬂuorine’s very high
ionization potential and low polarizability – ﬂuorinated mo-
lecules exhibit only weak intermolecular interactions, i.e. highly
ﬂuorinated compounds are characterized by weak surface ener-
gies, dielectric constants and refractive indices. In addition,
ﬂuorine has the highest electronegativity, and, thus, ﬂuorine–
carbon bonds are strongly polarized with the positive partial
charge at the carbon atom and the related negative partial charge
at the ﬂuorine atom. Therefore, C–F bonds possess stronger ener-
gies than the other C–Hal bonds and possess a high bond dis-
sociation energy.3 On the other hand, the hydrophobic character
of a molecule can be increased by the introduction of ﬂuorine
atoms.1,2
In this review we aim to present the most recent advances
in the ﬁeld of protein biosynthesis using ﬂuorinated amino
acids along with brief references to the benchmarks in related
peptide studies and the historical developments. Thus, our focus
is on in vivo synthesized proteins and the interested reader may
consult the literature for further details of the results in related
ﬁelds.4,5
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Effects of ﬂuorine incorporation into peptides and small proteins
As a result of numerous studies showing that ﬂuorinated amino
acids can increase the stability of natural polypeptides, ﬂuorine
has become of great interest in peptide and protein chemistry.
For example, ﬂuorinated derivatives could be used to investigate
the factors contributing to the extraordinary stability of col-
lagen.8 Collagen is the most abundant protein in animals as it is
part of connective tissues like bone, cartilage, ligament, skin and
teeth. The most characteristic features of this biopolymer are its
triple helical structure and its repetitive amino acid sequence
which is mostly composed of a Gly-Xaa-Yaa pattern with Xaa
and Yaa often either Pro or Hyp ((4R)-hydroxyproline, (4R-OH)
Pro). It was believed that the hydroxyl groups induce the confor-
mational stability of the triple helix by interstrand hydrogen
bonds mediated by bridging water molecules. In order to prove
this assumption, Hyp was replaced by (4R-F)Pro yielding a tre-
mendously increased triple-helical stability of the model peptide
compared to its hydroxylated counterpart (Tm of (Pro-Pro-
Gly)10: 41 °C, (Pro-Hyp-Gly)10: 69 °C, (Pro-(4R-F)Pro-Gly)10:
91 °C) (Fig. 1). This means, bridging water molecules contribute
little to collagen’s stability and inductive effects are much more
important. Additional explanations for the hyperstable triple
helix include the assumption of preorganization in terms of cis/
trans isomerization (all peptide bonds in collagen are in trans
and (4R-F)Pro favors trans conformation9), dipole interactions
and the gauche effect, as well as effects on the solvent-inaccess-
ible interstrand hydrogen bonds.6
The majority of the studies on “ﬂuorous proteins” were con-
ducted using peptides mainly synthesized chemically, such as
ﬂuorous bio-active peptides or ﬂuorous antimicrobial peptides.10
For example, Marsh and associates extensively studied the ther-
modynamics of ﬂuorinated peptides in comparison with their
non-ﬂuorinated counterparts. In particular, by using synthesized
peptides containing hexaﬂuoroleucine (Hﬂ, (5,5′-F6)Leu) they
found that ﬂuorination results in an increased thermodynamic
stability.10–12 The authors assumed a higher thermal stability and
an increased self-segregation of the peptides into antiparallel
4-helix bundles (Fig. 2) due to the ﬂuorous effect between the
ﬂuorinated amino acids based on the results of small ﬂuorocar-
bon molecules (vide infra). However, they found that the effect
of Hﬂ on stability strongly depends on the position of incorpor-
ation even if all ﬂuorinated peptides were more stable than the
ones without any ﬂuorine. Indeed, the most stable peptides in
terms of per-residue stability are these with Hﬂ in all ‘a’ or all
‘d’ positions of the helical peptide (Fig. 2), e.g. with an alter-
nating Leu-Hﬂ arrangement within the core. The sequence with
an entirely Hﬂ packed core had a lower per-residue stability but
was the most stable peptide in terms of absolute values. Thus,
efﬁcient packing of the ﬂuorous amino acids within the hydro-
phobic core is more important than the contribution of ﬂuoro-
carbon-ﬂuorocarbon interactions between ﬂuorinated side-chains.
This is an unexpected result, as the ﬂuorous effect would predict
that the ﬂuorinated side-chains should be close together in order
to interact. There are also examples in the literature which report
that ﬂuorination of amino acids leads to a decreased propensity
towards helix-formation.13 However, the arrangement with Hﬂ in
either position ‘a’ or ‘d’ provides the maximum dispersion of
ﬂuorinated side-chains throughout the structure. In addition, the
packing of the peptides was also investigated by studying the
generation of homotetramers and heterotetramers. In line with
the above mentioned results, the peptides preferred to form
homotetramers. Furthermore, the α-helix bundle peptides are
more resistant to proteolysis by trypsin and chymotrypsin using
Hﬂ as building block.14 It is also worth to note that they resist
unfolding by organic solvents better than their hydrocarbon
parent peptides. Similar results were also obtained for peptides
containing amino acids with only one triﬂuoromethyl group like
triﬂuoroleucine (Tﬂ, (5-F3)Leu) or triﬂuorovaline ((3-CF3)Val).
Both amino acids were incorporated into peptides similar to
parts of the transcription factor GCN4 or NTL9. In all cases a
stabilization of the peptides in terms of melting temperatures
could be achieved.15–17
Fig. 1 Unmodiﬁed, hydroxylated (natural) and ﬂuorinated (hyperstable) collagen peptides measured in 50 mM acetic acid. Unmodiﬁed (Pro-Pro-
Gly)10 collagen (A, Y = Pro) exhibits the lowest melting point (Tm = 41 °C) while the ‘natural’ (Pro-Hyp-Gly)10 sequence (B, Y = Hyp) is much more
stable (Tm = 69 °C) and, moreover, the ﬂuorine-containing (Pro-(4R-F)Pro-Gly)10 triple helix (C, Y = (4R-F)Pro) is hyperstable (Tm = 91 °C). The
trans-hydroxylation of Pro(Y) leads to an increase in Tm of almost 30 °C whereas its trans-ﬂuorination elevates melting temperature for almost 50 °C.
This is indeed plausible, since ﬂuorine exerts a strong inductive effect that is sufﬁcient to affect properties such as polarity or binding capacity of func-
tional groups that are even distantly positioned in the structure. The ﬁgure is adopted from ref 8.
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However, even though Marsh and co-workers revealed that
repacking of the hydrophobic core with Hﬂ in a series of pro-
gressively more ﬂuorinated four α-helix bundle peptides results
in an increase in free energy of folding, they assume that the six
ﬂuorine atoms in Hﬂ are not sufﬁcient to induce the so-called
ﬂuorous effect (vide infra).10 They claim that the stabilizing
effects detected originate from modulated hydrophobic inter-
actions due to the use of ﬂuorinated building blocks. However,
facing the enhanced stability they ask the question, “How stable
would a real ﬂuorous peptide be?” Most recently, the authors
solved X-ray structures of these peptides and their analysis sup-
ported the former ﬁndings that the stability increase could be
also explained by an increase in buried hydrophobic surface area
that accompanies ﬂuorination rather than by speciﬁc ﬂuorous
interactions between ﬂuorinated side chains.171 In fact even
extensive ﬂuorination of smaller peptides could preserve the
shape of the related side chains which is crucial for the correct
packing of side chains within the hydrophobic interior, while at
the same time delivering an increased size and hydrophobicity.
However, such preservation is difﬁcult in complex proteins and
would most probably compromise the functional integrity of the
protein.145
Other very interesting folding studies examine the effect of
ﬂuorine containing amino acids which are not derived from
hydrogen → ﬂuorine substitutions of canonical amino acids.18,19
Koksch and co-workers synthesized a 41 amino acid residue
containing α-helical coiled-coil peptide that folds into an anti-
parallel homodimer. Positions Lys8 and Leu9 were occupied by
either (CH3CH2)Gly (Abu), (CF2HCH2)Gly, (CF3CH2)Gly or
(CH3CF2CH2)Gly. Ala was used as control in position 8 and 9
as well. The ﬂuorinated amino acids were chosen due to the
widely accepted assumption that a triﬂuoromethyl group exhibits
approximately the same size as an isopropyl group20 and, thus,
(CF3CH2)Gly resembles Leu. Interestingly, all substitutions at
position 9 resulted in destabilized peptides as reﬂected by
15–22 K decreased melting temperatures. However, increasing
the side-chain volume by ﬂuorinated analogs caused increased
melting temperatures. Whereas the difference in Tm is only 0.4 K
for the peptides containing either (CH3CH2)Gly or (CF2HCH2)-
Gly, the difference is more pronounced (5 K) in case of the
peptide consisting of (CF3CH2)Gly. It is worth mentioning that
this shift is induced by a single additional H → F substitution.
However, an enlargement of the side-chain with a methyl group
as in (CH3CF2CH2)Gly resulted in a less stable peptide com-
pared to the (CF3CH2)Gly carrying peptide. Thus, the authors
conclude that destabilization increases along with the number of
alkyl hydrogen atoms polarized by ﬂuorine. In addition, alkyl
ﬂuorination induces electrostatic consequences by polarization
which affects the hydrophobic interactions to a greater extent
than the increased molecular volume perturbs the structural
integrity of the peptides. The substitutions of position Lys8 have
less pronounced effects on the stability. Here, the Tm is decreased
by only 2–5.6 K. This is due to the loss of one salt bridge upon
substitution. In this context, it should also be noted, that ﬂuorina-
tion of the solvent-exposed residue causes an additional loss in
stability. The authors hypothesized that ﬂuorine–ﬂuorine inter-
actions in the unfolded state have an impact on the monomer–
dimer equilibrium and performed self-replication studies via
native chemical ligation in the replicase reaction. The obser-
vation that the reaction rate decreases in correlation to an
increased number of ﬂuorine atoms in the side-chain might be
seen as an inhibition of the reaction cycle by F–F interactions
and prove that ﬂuorine prefers to interact with ﬂuorine in nature-
like protein environments. The studies on this model system
were continued and folding kinetics examined.21 Here, it could
be shown that ﬂuorination has its strongest impact on the
association of the coiled-coil peptides.
Another study investigated the stability of peptides by substi-
tuting all phenylalanine residues in a subdomain of chicken
villin headpiece (VHP, 35 residues, discrete tertiary structure)
with pentaﬂuorophenylalanine ((F5)Phe).
22 This amino acid was
chosen as there are several reports regarding the effects of ﬂuori-
nated saturated carbon atoms but only a few reports of the effects
of aromatic amino acids and their impact on stability. In order to
assay the conformational stability they performed a backbone
thioester exchange because this process can be easily monitored.
Model peptides containing three Phe residues were synthesized
on solid support in all possible combinations of (F5)Phe → Phe
substitution. Even though every variant adopted a stable tertiary
structure, only one out of seven ﬂuorine containing species dis-
played a greater conformational stability compared to the
ﬂuorine free peptide, whereas the other six peptides were less
Fig. 2 Helical wheel representation of 4-helix bundles arranged parallel (left panel) and antiparallel (right panel), respectively. Note, that in addition
to the differences in ‘a’ and ‘d’ interactions also the interactions between the other residues change (from ‘g’–‘e’-interaction to ‘g’–‘c’– and ‘b’–‘e’-
interactions).
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 7241–7261 | 7243
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stable. The reason for that might be found in steric repulsion due
to a slightly increased side-chain volume, and/or from minor
conformational rearrangements. However, the helical propensity
of (F5)Phe is lower compared to Phe.
13 In contrast, Zheng and
co-workers could show that one regioisomer of (F4)Phe, namely
(2,3,4,5-F4)Phe, at one out of three Phe positions stabilizes the
VHP peptide because of restored ArH⋯π interactions.23 The
four ﬂuorine atoms render the remaining ArH on the phenyl ring
more electron-deﬁcient in comparison to the unsubstituted
phenyl ring. This may leads to stronger ArH⋯π interactions in
case of (2,3,4,5-F4)Phe. However, for the same reasons ArH⋯π
interactions should be weakened if the π cloud is provided by the
ﬂuorinated phenyl ring.
Biological incorporation of ﬂuorinated amino acids into peptides
and proteins
The engineering of the genetic code has recently became an
important discipline in chemical biology as it provides an
efﬁcient platform for the transfer of numerous synthetic chem-
istries from the laboratory to the biochemistry of living cells.
This method also allows us to add ﬂuorinated non-canonical
amino acids (NCAAs) to the existing repertoire of the 20 canoni-
cal amino acids prescribed by the genetic code. Currently, two
approaches exist to ribosomally synthesize proteins using non-
canonical amino acids such as ﬂuorinated analogs (Scheme 1
and Scheme 2).24,25 The ﬁrst one, genetic code engineering,
makes use of amino acid auxotrophic cell strains and can be his-
torically traced back to the experiments of Cowie and Cohen.26
Whereas the experimental set-up is rather simple and very high
protein yields can be isolated following proper protocols, the
drawback of this method is that only NCAAs which are sufﬁ-
ciently similar to the original canonical amino acid can be in-
corporated. However, this approach suits very well for the
incorporation of ﬂuorinated amino acids, as the H → F substi-
tution can be considered as non-perturbing, as all endogenous
enzymes of the translational apparatus of cells accept almost all
monoﬂuorinated amino acids. In addition, this method allows for
studying synergistic effects of multiple-site incorporation27 as
well as for the efﬁcient incorporation of different NCAAs simul-
taneously.28,29 Due to the advantages of the method, most
experiments related to the incorporation of ﬂuorinated amino
acids were performed using this approach.24,25,30–33 The second
approach, genetic code expansion, has the major advantage of
being site-speciﬁc. This is achieved by manipulation of the
genetic template in terms of inserting an in-frame stop codon
into the coding sequence. This stop codon can be suppressed by
speciﬁc suppressor tRNAs charged with the desired NCAA
either chemically or enzymatically. The drawbacks of this
method are the time-consuming screening for effective ortho-
gonal tRNA/aaRS pairs allowing for efﬁcient suppression and
incorporation, and the limitation of the number of in-frame stop
codons to be effectively suppressed as well as the competition
with release factors.34
The auxotrophy-based approach
The history of the incorporation of NCAAs into proteins can be
traced back to the year 1951 in which Levine and Tarver reported
the incorporation of [14C]ethionine into tissue proteins.35 Six
years later, it was Cowie and Cohen who provided in their land-
mark experiment the ﬁrst demonstration of a proteome-wide
selenomethionine (SeMet) insertion in E. coli.26 To date, SeMet
is still the only analog known with such a great substitution
capacity. Regarding ﬂuorinated amino acids, it was in 1959
when Munier and Cohen reported the ﬁrst incorporation of
ﬂuorophenylalanine into bacterial proteins in vivo.36 Only two
years later it could be shown that mammalian proteins can be
Scheme 1 The genetic code including the structures of the canonical amino acids (left panel). In the right panel the two approaches for the incorpor-
ation of non-canonical amino acids are outlined. A site-speciﬁc incorporation of e.g. 4-triﬂuoromethyl-phenylalanine is possible by suppression of an
in-frame stop codon by a special tRNAwhich is charged by a cognate aminoacyl-tRNA synthetase (aaRS). On the other hand, auxotrophic host cell
provide a possibility to incorporate non-canonical amino acids residue-speciﬁc. Further details, advantages and disadvantages of both methods are
described in the text.
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ﬂuorinated by feeding rabbits with 4-ﬂuorophenylalanine ((4-F)-
Phe).37 This approach was later used in order to perform NMR
studies.38 In 1962, Richmond summarized for the ﬁrst time the
results of NCAA incorporation into proteins in his review
entitled ‘The Effect of Amino Acid Analogues on Growth and
Protein Synthesis in Microorganisms’.39 In the same year,
Chapeville and co-workers reported the ﬁrst results of amino
acid incorporation by using misacylated tRNAs in ribosomal
protein synthesis.40 By supplementing growth medium with Tﬂ,
Rennert and Anker showed one year later that an exponential
Scheme 2 Survey of ﬂuorinated non-canonical amino acids mentioned in this review. The blue formulas represent the hydrocarbon or canonical
counterparts to be substituted and used as controls. (A) Amino acids used only in peptide studies to date, (B) amino acids used in peptide studies and
predominantly in genetic code engineering and (C) amino acids used in peptide studies and in genetic code expansion. Amino acids marked with an
asterisk could not be incorporated to date in vivo.
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 7241–7261 | 7245
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growth can be detected and the ﬂuorinated amino acid is incor-
porated into proteins.41 At the same time, Conway and co-
workers studied the effect of ﬂuorinated Phe analogs on the
intracellular accumulation of Phe and its incorporation.42 In the
mid-1970s, the ﬁrst reports appeared exploring the suitability of
ﬂuorinated protein congeners for 19F NMR structural analysis.
Sykes and co-workers studied the alkaline-phosphatase equipped
with ﬂuorotryptophans,43 whereas Pratt and Ho examined
D-lactate dehydrogenase and lactose permease,44 also with in-
corporated ﬂuorotryptophans. Here, up to two doublings could
be detected during cell growth but most congeners – non-canonical
amino acid bearing proteins – exhibited a reduced activity.
However, 4-ﬂuorotryptophan ((4-F)Trp) in D-lactate dehydro-
genase showed an enhanced activity which is the ﬁrst report
of a positive effect of ﬂuorinated amino acids on the activity of
an enzyme. In the following years, ﬂuorinated amino acids
became a widely used tool in structural NMR analysis of
proteins.45–51
Also in the 1970s, the ﬁrst experiments using 2-ﬂuorohistidine
((2-F)His) for protein biosynthesis were reported. Its biological
effects and its incorporation into (mammalian) proteins were
studied.52–54 (2-F)His is an interesting amino acid as its pKa is
lowered by 4.8 units compared to His and, thus, its incorporation
may affect catalysis.54 Taylor and co-workers published a crystal
structure of the semisynthetic ribonuclease-S with incorporated
4-ﬂuorohistidine ((4-F)His) in 1981.55 However, the enzyme was
inactivated due to the altered basicity of the catalytic active
His12.
Another benchmark experiment of the 1980s was performed
by Wong who showed that by serial dilution experiments, micro-
organisms can be generated which have a stronger preference to
grow on (4-F)Trp than on Trp itself.56 Similar experiments were
attempted by Bacher and Ellington some years later (vide infra)
but so far without success.57,58 In 1988, Bronskill and Wong
demonstrated that (4-F)Trp could not only be used in 19F NMR
analysis but also facilitates the identiﬁcation of the contribution
of chromophores, like Tyr or Phe, to the spectroscopic features
of a protein as (4-F)Trp itself is a non-ﬂuorescent Trp analog.59
In addition, ﬂuorinated Trp analogs have in general been com-
monly used to perform spectroscopic and unfolding studies (vide
infra and e.g. ref. 60 and 61). In 1997, Duewel and co-workers
conﬁrmed the in vivo incorporation of triﬂuoromethionine (Tfm)
into a phage lysozyme.62 They characterized for the ﬁrst time an
enzyme with Tfm as the reports of 1975 only provided indirect
evidence for Tfm incorporation into TCA-insoluble protein frac-
tions from S. cerevisiae.63
Our group also became interested in ﬂuorinated proteins by
the end of the 1990s. One of the ﬁrst experiments was the quan-
titative incorporation of either (4-F)Trp, (5-F)Trp, or (6-F)Trp
into human annexin V (anxA5).64 As judged from X-ray analy-
sis, the congeners had the same secondary and tertiary structure
as the parent protein. However, the congeners differed in stab-
ility, folding cooperativity, biological activity and ﬂuorescence
properties compared to the parent protein. As expected, the (4-F)-
Trp congener exhibited no ﬂuorescence, whereas the (5-F)Trp
and (6-F)Trp congener exhibited similar emission proﬁles as the
parent protein but red-shifted by 13 and 16 nm, respectively.
Comparison of the Tm values revealed that anxA5[(5-F)Trp] is
more stable compared to the parent protein and the other two
congeners are less stable (vide infra). The biological activity
assays showed that the (6-F)Trp congener is threefold more
active compared to the parent protein. In contrast, incorporation
of (4-F)Trp or (5-F)Trp decreased the activity three- and
twofold, respectively. In addition, it is important to mention that
anxA5[(5-F)Trp] and anxA5[(6-F)Trp] still crystallized under the
same conditions as wild-type anxA5 itself. In contrast, it was
impossible for Minks and co-workers to crystallize the congener
anxA5[(4-F)Trp]. However, they argued that the overall structure
is not affected by incorporation of (4-F)Trp due to the super-
imposable CD proﬁles and similar behavior during thermal
denaturation.
Interestingly, this study reports the ﬁrst efforts to produce a
data set of molecular packing of ﬂuorine-containing amino acids
within a complex protein structure. Molecular modeling was
carried out on the basis of the available high-resolution crystal
structures. Calculation of the exclusion volumes revealed tighter
packing of the parent protein anxA5 and anxA5[(5-F)Trp]
whereas the packing of 4-FTrp and 6-FTrp (Fig. 3) into the core
of anxA5 seems to be less tight by a factor of 14 compared to the
parent protein, and therefore indicating possible unfavorable
electrostatic or even steric interactions. Interestingly, these
ﬁndings correlate well with the thermodynamic stabilities and
activity data. Unfortunately these interesting ﬁndings were not
further studied and elaborated upon using other proteins or
model systems.
Fig. 3 Packing of ﬂuorinated Trp187 in human annexin V (anxA5)
revealed by three-dimensional modeling of the gap regions in Trp’s
cavity. Ribbon plot of the three-dimensional structure of anxA5 with
single Trp187 marked as balls-and-sticks (lower part) along with the cal-
culated gap areas marked in blue (upper part). (A) Native Trp187
occupies 73.7 Å3 of the space (excluded volume) in its hydrophobic
niche; (B) In the anxA5[(5-F)Trp] there is no signiﬁcant change in the
excluded volume in comparison to the native counterpart; (C) (4-F)Trp
insertion into anxA5 is accompanied with an increase of the excluded
volume of approximately 14 (91.9 Å
3) in comparison to the native
protein. D) anxA5[(6-F)Trp] has also a signiﬁcantly increased excluded
volume in comparison to the native form and similar to that of the
4-FTrp substituted protein.64.
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AnxA5 proved to be a good model protein and was used in
further studies in our lab along with azurin from Pseudomonas
aeruginosa for the incorporation of (3-F)Tyr.65 Again, there are
no dramatic changes in ﬂuorescence and CD proﬁles upon incor-
poration of the analog and the thermal stability is comparable to
that of the parent proteins with azurin[(3-F)Tyr] being slightly
more stable compared to azurin itself. However, anxA5[(3-F)-
Tyr] is approximately threefold less active than anxA5 whereas
electron transfer processes in azurin seemed not to be altered
upon ﬂuorination. Examples of other groups in which ﬂuorina-
tion of tyrosine alters enzyme activity include β-galactosidase
(ﬂuorination was used to probe whether Tyr is part of the cata-
lytically active portion of the protein),66,67 ketosteroid isomerase
from Pseudomonas testosterone68 and rat glutathione transferase
M1-1.69 These ﬂuorinated proteins are interesting because of
their altered pKa. Remember, the pKa of the phenolic proton
which is 10 in tyrosine varies between 5.2 and 9.0 in its ﬂuori-
nated analogs depending on the level and position of ﬂuorina-
tion.68,70 Thus, the ﬂuorinated Tyr analogs can be used in order
to investigate acid-base catalysis or redox potential properties.
In addition, ﬂuorinated tyrosine radicals are characterized by
peak reduction potentials between 705 and 968 mV whereas Tyr
as a reduction potential of 642 mV.71
We could also achieve high incorporation levels of ﬂuorinated
Phe derivatives into anxA5 and azurin.72 Thereby, we observed
characteristic absorption maxima in the UV/Vis spectra of the
ﬂuorinated amino acid analogs as well as the related protein con-
geners. These arising maxima can be interpreted as ﬁngerprints
of the related (F)Phe and are termed “ﬂuorophenyl-ﬁngers”.
The protein yields decreased in the order (2-F)Phe≫ (3-F)Phe >
(4-F)Phe for both proteins but the trends are less pronounced in
the case of azurin. As before, the structural integrity of the pro-
teins were not affected by NCAA incorporation. The practical
importance of these experiments can easily be recognized: The
“ﬂuorophenyl-ﬁngers” appear in the UV-spectrum in the range
of 260–270 nm and do not overlap with the contributions of
tyrosine and tryptophan residues in the protein UV-spectra.
Thus, ﬂuorinated phenylalanines, especially those ﬂuorinated at
the ortho-position of the Phe-ring could be used as markers as
they do not affect protein structure or activity and appear exclu-
sively in the chromatographic fractions that contain the target
proteins. In other words, the presence of such “ﬂuorophenyl-
ﬁngers” (“FF-ﬁngers”) represents a unique spectroscopic probe
to identify the labeled target protein among other non-labeled
cellular proteins in preparative work by simple UV spectroscopy.
In the coming era of proteomics such reliable, cheap and easy to
reproduce methodology might have a great potential for high-
throughput identiﬁcation and characterization of target molecules
in total protein output of a variety of organisms.72
The stop codon suppression (SCS) methodology
In 1992, Ellman and co-workers reported an NMR study of T4
lysozyme in which they introduced site-speciﬁcally [13C]Ala for
the purpose of NMR analysis by in vitro synthesis of the
protein.73,74 However, despite this and all related studies afford-
ing an enormous amount of useful information, the in vivo incor-
poration of NCAA is still the most prominent goal to achieve.
In 1998, Furter performed the ﬁrst in vivo incorporation of ﬂuori-
nated amino acid using the in-frame stop codon suppression
methodology.33 He introduced an amber stop codon into murine
dehydrofolate reductase (mDHFR) and it was translated with
(4-F)Trp with approx. 64–75% efﬁciency (the remainder was
translated as Phe or Lys). In addition, he detected also some
(4-F)Phe incorporation at Phe positions which can be explained
by the substrate tolerance of the endogenous enzymes, which is
exploited in genetic code engineering. The expression level of
the mDHFR congener was about 2/3 of the parent protein. By
using a yeast tRNAPhe/PheRS system in Phe-auxotrophic E. coli
strains he started what is now dubbed genetic code expansion.
However, only in 2007 the ﬁrst successful incorporation of a
ﬂuorinated amino acid in a totally site-speciﬁc manner by incor-
porating 4-triﬂuoromethyl-phenylalanine (4-CF3)Phe into either
nitroreductase or histidinol dehydrogenase was reported.75 Both
enzymes are functional only as dimers meaning the activity is a
measure of structural integrity. The evolution of an orthogonal
pair capable for (4-CF3)Phe incorporation was performed by
positive and negative selection starting from a Methanocaldococ-
cus jannaschii suppressor tRNA/aminoacyl-tRNA synthetase
pair.76 From the two candidates identiﬁed only one was further
investigated. In contrast to former systems, the expression
yielded protein amounts comparable to the parent proteins.
Nitroreductase labeled at different positions with the ﬂuorinated
amino acid was used to assay the binding of substrates and inhi-
bition, respectively. Therefore, mutants were generated varying
the distance of the active site and the TAG codon/ﬂuorine label
from rather long distances to short-distances. However, the intro-
duction of (4-CF3)Phe had only minor effects on the activity.
In addition, the authors measured the chemical shift sensitivity
of position 36 and 124 in response to conformational changes by
the addition of a competitive inhibitor, and if the cofactor ﬂavin
mononucleotide (FMN) was reduced and oxidized. It turned out,
that position 36 is not as sensitive as position 124 with regard to
conformational changes. The other enzyme studied, histidinol
dehydrogenase, is a metallo-enzyme. It was studied to determine
whether a conformational change occurs by the addition of Mn2+
or histidinol alone. However, no change was detectable. In con-
trast, by adding both compounds together, a shift of the NMR
signals could be detected. Furthermore, 19F NMR could also be
performed in vivo with the ﬂuorinated congener of nitroreduc-
tase. Whereas the ﬁrst in vivo 19F NMR studies examined the
mobility of proteins, e.g. in Saccharomyces cerevisiae,77–79
(4-CF3)Phe probes can be used for deeper investigations. This
was shown by the incorporation of this amino acid into several
globular proteins in the range of 7 to 100 kDa.80 In a ﬁrst series
of experiments congeners harboring (3-F)Tyr were used and the
data were mostly in accordance with the literature.51 However, to
gain a better resolution the ﬂuorinated Phe analog (4-CF3)Phe
was introduced to the proteins leading to more detailed results.
From these studies, it can be deduced that (4-CF3)Phe could
be a useful tool to examine large-sized proteins as well as
protein complexes as the independent internal motion of the tri-
ﬂuoromethyl group of the ﬂuorinated amino acid sharpens the
resonance and facilitates the detection of larger globular proteins.
(4-CF3)Phe was also used in relaxation analysis. Here, the
advantage of the fast rotational motion of the CF3 group around
the C–C bond could be exploited. The 19F T1 value of free
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 7241–7261 | 7247
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(4-CF3)Phe is 200 fold shorter compared to the T1 of (4-F)Phe
(1.47/352 s).81 In addition, in (4-F)Phe the 19F spin is directly
bonded to the aromatic moiety. Thus, (4-CF3)Phe is better suited
for chemical shift and relaxation studies. Examples include the
human vinexin SH3 domain which upon (4-CF3)Phe incorpo-
ration revealed different internal motions upon ligand binding
via relaxation analysis,82 as well as a nine-transmembrane
helices membrane protein trimer of diacyl-glycerol kinase
(DAGK) in dodecyl phosphocholine (DPC) micelles.83
(4-CF3)Phe is not the only ﬂuorinated aromatic acid which
can be incorporated in response to an in-frame stop codon. For
instance, (4-F)Bpa, (2,6-F2)Bpa and (3-F, 4-NO2)Bpa could be
incorporated84 with varying yields into a mutant superfolder
GFP85 (V150TAG, His-tagged). By mutations of the BpaRS,
they generated various synthetases which differ in permissivity.
It is worth to note, that some of these mutants were much more
effective for incorporation of particular NCAAs. The authors
also identiﬁed a mutant of NapRS suitable for 4F-Bpa incorpor-
ation. Mehl and co-workers also used their superfolder GFP
mutant as model for their attempts to evolve aaRS for (4-CF3)-
Phe and other ﬂuorinated amino acids such as (3-F, 4-CH3)Phe,
(3-F, 4-CF3)Phe, (2,3-F2, 4-CH3)Phe and (2,3,5,6-F4, 4-CH3)-
Phe.86 They started their evolution with a modiﬁed Methanocal-
dococcus jannaschii tyrosyl-tRNA synthetase/tRNACUA pair
87
and were able to select for enzymes which incorporated the
desired amino acids into chloramphenicol acetyltransferase and
superfolder GFP. Whereas, for example (3-F, 4-CH3)Phe gives
50% of the parent protein yield, (4-CF3)Phe yields only approx.
20%. However, the authors noted that the isolated yields do not
match the examined in vivo yields which they attribute to pro-
blems during the puriﬁcation procedure. Even though the two
mentioned amino acids ((3-F, 4-CH3)Phe and (4-CF3)Phe) are
very similar in their structure, their related aaRS differ in
sequence and their ability to charge tRNAs. In addition, both
enzymes were capable of incorporating at least some of the other
ﬂuorinated amino acids under investigation, with the size of the
p-substituent proving to be crucial. The authors also report the
generation of a hybrid aaRS bearing elements from both
enzymes and, thereby, increasing the ability of incorporation of
ﬂuorinated amino acids. For their subsequent NMR studies, they
incorporated (4-CF3)Phe, (3-F, 4-CH3)Phe, and (3-F, 4-CF3)Phe
into superfolder GFP at positions 134 (loop), 146 (near the
ﬂuorophore) and 150 (surface of the β-barrel). Here, they
observed that the signals expectedly varied from sharp to broad.
The amino acid (4-OCF3)Phe was incorporated into the
33 kDa thioesterase domain of the human fatty acid
synthase.88,89 This was combined with the incorporation of 13C
and 15N labeled amino acids into 11 different positions around
the active site in response to a TAG amber stop codon in order to
probe the structure, dynamics and ligand binding of the protein.
In addition to the development of a tRNA/aaRS pair speciﬁc for
(4-OCF3)Phe, improved yields of protein (2 mg of 50 mL
culture in average for all mutants) could be achieved. The advan-
tage of this method is the successful peak assignment in contrast
to former studies of large proteins such as the 100 kDa citrate
synthase with incorporated (5-F)Trp77 or the 210 kDa trimeric
pyruvate kinase also labeled with (5-F)Trp.78 However, the ﬁrst
study revealed that the citrate synthase is motionally restricted
in vivo.
Fluorinated tyrosines are commonly introduced into proteins
by genetic code engineering, as the endogenous enzymes
accept them as substrate.24,65 However, recently Wilkins and co-
workers could show that these amino acids can also be incorpo-
rated by in-frame stop codon suppression. The only prerequisite
is a masking before incorporation.90 The ﬂuorinated Tyr analogs
can be masked, for instance, with photoremovable protecting
groups.91–93 In that way, incorporation of o-nitrobenzyl-2-ﬂuoro-
tyrosine, -3-ﬂuorotyrosine and -2,6-diﬂuorotyrosine into super-
folder GFP in E. coli was achieved. They started the evolution of
the orthogonal pair from a mutant of the Methanocaldococcus
jannaschii tyrosyl-tRNA synthetase for the incorporation of
o-nitrobenzyltyrosine.94 When the three analogs were incorpo-
rated into the chromophore (Tyr66), the 2-ﬂuoro and the 2,6-
diﬂuoro derivative exhibited a blue shift in the emission proﬁles
of the superfolder GFP (503 and 509 nm compared to 513 of the
parent protein). In contrast, ﬂuorine in position 3 leads to a small
red shift (515 nm). Thus, the ﬂuorescence properties can be
altered in different ways using ﬂuorinated Tyr residues. This is
also in line with experimental data gained by genetic code engi-
neering with enhanced green ﬂuorescent protein (EGFP) as model
protein (vide infra).95,96 In addition, it is worth to note that even
if the protecting group still blocks the tyrosine hydroxyl, the
ﬂuorescence maximum of the 2-ﬂuoro derivative has an emis-
sion maximum at 503 nm. However, the intensity is decreased
by approx 340% and the folding as well as the maturation state
with protected ﬂuorotyrosines is not clear yet.
Very recently, Schultz and co-workers reported an evolved
aaRS with broad polysubstrate speciﬁcity.97 They screened for
the incorporation of (4-F)Phe as well as for p-triﬂuoromethyl-
acetylphenylalanine among 17 other aromatic NCAAs. Here,
they used a GFP-based screening system for incorporation and
validated this by incorporation of the NCAAs into a His-tagged
myoglobin mutant which could be expressed in levels up to 45%
in the presence of the ﬂuorinated non-canonical amino acids
compared to the parent protein.
Aliphatic ﬂuorinated amino acids can also be incorporated via
the suppression-based approach.98 Indeed, Hancock and co-
workers could demonstrate that Nε-triﬂuoroacetyl-L-lysine
((Nε-COCF3)Lys) can be incorporated into proteins of S. cerevi-
siae via a tRNA/aaRS pair which is based upon a pair evolved
earlier for Nε-acetyl-L-lysine. In this way, they provided an effec-
tive system for the creation of orthogonal pairs in E. coli which
can be used to expand the genetic code of yeast.
Fluorination of enzymes
Already some early studies investigated the effect of ﬂuorinated
amino acids on the catalytic activity. For example, Ho and co-
workers analyzed the inﬂuence of ﬂuorinated aromatic amino
acids on the activity of D-lactate dehydrogenase of E. coli.44,99–101
Brooks and co-workers studied the effects of (2-F)Tyr, (3-F)Tyr
and (2,3-F2)Tyr on the catalytic activity of ketosteroid isomerase
of Pseudomonas testosterone68 whereas Ring and co-workers
used (3-F)Tyr to identify a catalytically active Tyr residue in
β-galactosidase.66 In addition, Xiao and co-workers used these
analogs to probe the structure and function of rat glutathione
transferase M1-1.69 More recently, the effect of ﬂuorophenylala-
nine on the activity of PvuII endonuclease has been studied.102
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(2-F)Phe, (3-F)Phe or (4-F)Phe were incorporated at the four Phe
sites of each subunit. Despite the low incorporation efﬁciency
with respect to ﬂuorination (7–17%), this modiﬁcation resulted
in strong effects on the catalytic activity. Whereas the catalytic
speciﬁcity was the same for the parent protein and all other con-
geners, the congener carrying (2-F)Phe was as active as the
parent protein but the one with (3-F)Phe was approximately
twofold more active than the parent protein. Interestingly, the
enzyme with (4-F)Phe in its amino acid sequence had a fourfold
decreased activity compared to the Phe containing protein. Also
the conformational stability of this congener was decreased as
judged from unfolding experiments. A similar trend was
observed by the Schultz lab in their in vitro experiments using
ﬂuorinated Tyr analogs and Staphylococcal nuclease.103 In
addition, a (3-F)Phe bearing congener of galactose binding
protein also showed a signiﬁcant decreased ligand afﬁnity and a
decreased stability in comparison with the parent protein.104
In 2009, Voloshchuk and co-workers introduced ﬂuorinated
phenylalanines into the histone acetyltransferase.105 Again, the
regioisomers differ in their effects on stability and catalytic
activity. However, all of them showed decreased values for these
properties. Interestingly, the three ﬂuorinated congeners were
also more prone to proteolytic digestion than the parent protein,
which is in contrast to other examples in the literature.106 Most
recently, Baker and Montclare published their results on the
effect of (4-F)Phe on the structural integrity and catalytic activity
of S5 phosphotriesterase.107 The ﬂuorinated congener of this
protein showed enhanced refolding properties. It is worth to note
that ﬂuorination has different effects on different substrates, as
the congeners can exhibit higher and lower kcat/kM values com-
pared to the parent protein. It should also be mentioned that
subtle changes in structure and side-chain interactions/directions
of ﬂuorine containing proteins compared to the respective parent
protein have been observed in several studies which may account
for the decreased stability.69,95,108,109
The lab of Montclare also studied the effect of aliphatic amino
acid ﬂuorination on the catalytic performance of enzymes. For
example, they incorporated Tﬂ into the chloramphenicol acetyl-
transferase.110 This protein was chosen as its 13 Leu residues are
not involved in substrate recognition or catalysis and the function
can be assayed very easily. They found that ﬂuorination in an
efﬁciency of up to 80% has no effect on the catalytic activity.
However, thermo- and chemostability were markedly decreased.
This is interesting since they detected the biopolymer being
more structured upon ﬂuorination; i.e. an enhanced secondary
structure does not lead automatically to an enhanced stability
(vide infra).
A more systematic study was presented by Hoesl and co-
workers who investigated the effect of various amino acids on
the lipase of Thermoanaerobacter thermohydrosulfuricus
(TTL).111 The amino acids studied included ﬂuorinated deriva-
tives such as (3-F)Phe, (4-F)Phe, (4S-F)Pro, (4R-F)Pro, (2-F)Tyr
and (3-F)Tyr. The lipase consists of 6 Pro residues, 16 Phe resi-
dues and 7 Tyr residues (Fig. 4). Whereas the ﬂuorinated Pro
analogs gave only slightly higher yields compared to the parent
protein, the Phe analogs gave much higher yields (up to three-
fold increase).Tyr analogs, however, yielded lower amounts of
protein. The incorporation efﬁciencies of (4S-F)Pro and the Tyr
analogs were very good but substitution with ﬂuorinated Phe
analogs and (4R-F)Pro could be only achieved with a low
efﬁciency. Regarding the catalytic parameters, none of the con-
geners showed a higher optimal temperature Topt than the parent
protein but the (3-F)Phe and (2-F)Tyr congeners retained the
70 °C from the parent protein. Interestingly, the regioisomers
have quite different Topt (3-F)Tyr and (4-F)Phe perform best at
50 °C as well as the congeners containing ﬂuorinated Pro resi-
dues. With the exception of the (4R-F)Pro congener, all con-
geners show a high thermal stability (75 °C for 180 min). The
proteins harboring (4S-F)Pro, (4-F)Phe as well as (3-F)Tyr were
stable even far above their optimal temperature. A characteristic
feature of the lipase is its ability to be activated by heat. For the
ﬂuorinated Tyr and Phe residues, activity changes with tempera-
ture and is again regioisomer dependent: (3-F)Phe is especially
beneﬁcial for the activity whereas (4-F)Phe impairs the activity
of the lipase. And whereas the (3-F)Tyr congener is mainly in-
active, the one bearing (2-F)Tyr is, after thermal activation, fully
active. In the case of (3-F)Phe incorporation, the substrate
tolerance of the resulting protein congener was also affected.
This congener shows a broader tolerance compared to the parent
protein. Interestingly, in case of the proline analogs, no signiﬁ-
cant heat activation could be detected.
Finally, Wiltschi and co-workers studied the effects of ﬂuori-
nated CalB expressed in yeast.106 A glycosylation-deﬁcient
mutant of Candida antarctica lipase B was expressed in Pichia
pastoris and the protein segregated to the medium. The analogs
(5-F)Trp, (3-F)Tyr or (4-F)Phe were used for incorporation
experiments. However, homogenous samples could not be iso-
lated in any case. The mixtures of ﬂuorinated protein species
were further analyzed, revealing that the ﬂuorinated congeners
were still active, albeit with lower activity. But even with the
resistance to proteolytic degradation by proteinase K remaining
unchanged, the authors could observe a prolonged shelf life of
the lipase activity upon ﬂuorination. The secondary structure
analysis revealed some slight changes after ﬂuorine incorpo-
ration, especially for (3-F)Tyr. In this variant, the content of
random coils was increased. Thus, Tyr might be important for
the structural integrity of the protein. This could be also argued
from the changes in ﬂuorescence emission spectra upon protein
ﬂuorination.
In addition to experimental work, calculations have been per-
formed. For instance, the biotin binding ability of streptavidin in
correlation to the ﬂuorination of tryptophan residues was investi-
gated.112 It turned out, that in this case protein stability and
folding are only weakly affected by ﬂuorination of the Trp resi-
dues. The binding abilities of the congeners can be predicted to
be decreased or increased depending on the position of the
ﬂuorine substituent.
Generally speaking, the majority of successful mono-ﬂuori-
nated amino acid substitutions so far introduced in recombinant
proteins are found to be structurally neutral. However, such
ﬂuorinations are usually accompanied by the emergence of novel
spectral, structural, and enzymatic properties. As already dis-
cussed, Ring et al.66,67 probed the role of catalytic Tyr in the
active center of β-galactosidase by the global replacement of all
Tyr-side chains with (3-F)Tyr, whereas Brooks and co-workers
used (2-F)Tyr to dissect the catalytic mechanism of ketosteroid
isomerase.68 More recently, interesting spectral and dynamic
properties of green ﬂuorescent protein upon global substitution
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 7241–7261 | 7249
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of its Tyr-residues with (2-F)Tyr and (3-F)Tyr were reported as
well (vide infra).95,96 Similarly, the appearance of “ﬂuorophenyl-
ﬁngers” discussed above represents a non-invasive ﬂuorinated
optical probe designed to introduce dramatic changes in the
spectral properties of the protein without compromising its stabi-
lity and/or biological activity.72 Finally, these ﬁndings and our
recent success to generate ﬂuorinated lipase congeners with elev-
ated enzyme activity, enhanced substrate tolerance and dramatic
changes in the enzymes’ temperature optimum represent a solid
basis for the design new classes of ﬂuorine-containing protein-
based biocatalysts.
Fluorination of Pro residues in proteins
According to peptide studies, the ﬂuorination of Pro residues can
have a strong impact on the stability and folding characteristics
of the related peptide. Pro is the only imino acid among the
canonical amino acids and is often present in structural import
positions in peptides and proteins, for instance in turns, and
despite being a common feature of helices, it can also act as a
helix breaker. It is hypothesized that the ﬂuorination of position
4 of the pyrrolidine ring affects preorganization principles and
that there is a stereochemical bias in folding. This is due to the
fact that the stereoelectronic effects of the C4-substituent
inﬂuence the cis/trans ratio of the prolyl peptide bond as well as
the pucker of the pyrrolidine ring (Fig. 5). Indeed, (4R-F)Pro
favors the Cγ-exo puckering whereas (4S-F)Pro prefers Cγ-endo
puckering as determined in 1973 for the ﬁrst time113 and
conﬁrmed in several studies.9,114–120 These preferences can be
explained by the gauche effect. In the Cγ-exo pucker, an n → π*
interaction between oxygen of the Xaa-Pro peptide bond and the
carbon of the Pro-Yaa peptide bond can be observed, which
stabilizes trans peptide bonds. In contrast, Cγ-endo favors a cis
peptide bond. This leads to the assumption that the bias of (4-F)-
Pro to adopt either an exo or endo puckering can have antagon-
istic effects on peptide/protein stability, depending on the puck-
ering and the structural context in the natural state. For example,
incorporation of (4S-F)Pro into collagen and its natural precur-
sors was performed in cell culture already in 1974.121 This incor-
poration yielded a destabilization as well as a decrease in folding
rate of the collagen triple helix. Conversely, in 1999 it was
shown that synthetic collagen peptides bearing (4R-F)Pro
are characterized by an increased stability of the triple helix
(vide supra).8
As the puckering has an impact on the peptidyl prolyl bond
conformation, the peptidyl prolyl cis/trans isomerase (PPlase)
reaction was investigated with substrates bearing (4-F)Pro.122
The 4S as well as the 4R isomers of the amino acid were used in
Fig. 4 Inﬂuence of the incorporation of monoﬂuorinated Tyr and Phe residues on the enzyme activity of lipase. (Left) Three dimensional models of
lipase from Thermoanaerobacter thermohydrosulfuricus (TTL) with marked Tyr (A) and Phe (B) residues (one-letter code). Following substitutions
have been performed: Tyr → (3-F)Tyr, and (2-F)Tyr; Phe→ (3-F)Phe), (4-F)Phe. (Right) Results of the activity assays with 1: TTL, 2: TTL[(3-F)Phe],
3: TTL[(4-F)Phe], 4: TTL[(3-F)Tyr] and 5: TTL[(2-F)Tyr]. The lipase is almost not active prior to heat activation (C). Upon activation (D) TTL[(3-F)-
Phe] and (TTL[(2-F)Tyr]) along with parent TTL are highly active. The other two ﬂuorinated TTL variants exhibit rater modest activity (TTL[(4-F)-
Phe]) (TTL[(3-F)Tyr]). In general, while crystallographic and modeled structures of these proteins are indistinguishable from their native counterparts
(i.e. they are almost perfectly isomorphous), there are considerable differences in their enzymatic properties.
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order to study the kinetics and the molecular principles of the
enzyme’s substrate speciﬁcity as the Pro residue at position P1′
of the substrate is assumed to govern the recognition process.
In order to assay the effects of the ﬂuorinated derivatives, a tetra-
peptide as well as mutants of the nuclease inhibitor barstar (b*)
were used. Barstar is a small protein and a well-known folding
model. The mutant protein used here had a single Pro residue
which exhibits a trans conformation in the unfolded state and a
cis conformation in the native state. Most PPIases tested showed
a preferred stereospeciﬁcity for the b*[(4S-F)Pro] congener, with
one exception, (E. coli Par10). The authors could also detect a
difference between the model peptides and the related proteins in
their susceptibility to PPIase catalysis. However, spontaneous
isomerization is not affected by ﬂuorination of the C4 of the
pyrrolidine ring.
Renner and co-workers also used model peptides and barstar
for folding and stability studies.9 These studies conﬁrmed the
preference of (4S-F)Pro for a cis conformation and the preferred
trans conformation for (4R-F)Pro. They also conﬁrmed the pre-
ferred puckers (Pro, (4S-F)Pro and (4-F2)Pro adopt an C
γ-endo
pucker, (4R-F)Pro exhibits an Cγ-exo pucker). By supplementing
the medium with (4-F)Pro for the in vivo expression of the
barstar mutant with a single Pro residue, they could demonstrate
that incorporation of (4S-F)Pro leads to a more stable and (4R-F)-
Pro to a less stable congener compared to the parent protein.
This is due to the fact that Pro48 of barstar prefers cis confor-
mation, which is in accordance with the expectations. Interest-
ingly, (4-F2)Pro did not have an effect on thermal stability.
However, the situation regarding the effects of (4-F)Pro incor-
poration is inversed in the Trp cage miniprotein.123 Here, a trans
proline bond is present in the model compound and Naduthambi
and Zondlo equipped the peptide in vitro with different substitu-
ents in position four including (4S-F)Pro and (4R-F)Pro. This
allowed them to tune the stability of the peptide in a range of
50 °C. Interestingly, Cγ endo-favoring residues (such as (4S-F)-
Pro) at the essential Position Pro12 destabilize the structure,
whereas Cγ exo-favoring residues (such as (4R-F)Pro) at that pos-
ition stabilize the peptide. Other peptide studies evaluated the
ring puckering effects on the conformational preferences of
human prolyl 4-hydroxylase.124,125
Returning to the in vivo incorporation of (4-F)Pro into
proteins, the results of the Conticello lab have to be
considered.126–128 They attempted to incorporate (4R-F)Pro,
(4S-F)Pro as well as (4-F2)Pro into a elastin-mimetic polypeptide
with 20% Pro residues in the repetitive domain. Whereas the
monoﬂuorinated Pro analogs could easily be incorporated by a
Pro auxotrophic E. coli strain, the diﬂuoro analog (4-F2)Pro
required changes in the expression protocol, i.e. the co-
expression of the wild-type aminoacyl-tRNA synthetase. It is
worth to note that by hyperosmotic concentrations of osmolytes
in the media the protein yields could be enhanced in a concen-
tration dependent manner. This is explained by former studies
showing that the biosynthesis of endogenous low-afﬁnity proline
transporters can be up-regulated by hyperosmotic induc-
tion.129,130 In their study, the authors also conﬁrmed, that the
yield of protein expression in the presence of NCAA depends on
the host-cell physiology, model protein and experimental con-
ditions by using a variety of analogs. Furthermore, Conticello
and co-workers investigated the effects of the incorporated
epimers on the self-assembly of the related polypeptides. The
transition temperature (Tt) from a random coil conformation to a
more ordered one was determined to be 33 °C for the proline
bearing parent protein. The congener with (4S-F)Pro had a Tt of
41 °C and the one carrying (4R-F)Pro had a Tt of 22 °C as deter-
mined by differential scanning calorimetry (DSC).128 Measuring
CD spectra, the authors could show that the regioisomers again
have different inﬂuences on the secondary structure. For
example, increasing the temperature leads to CD proﬁles indicat-
ing a higher content of type II β-turn structures for the parent
protein as well as the (4R-F)Pro congener. In contrast, the proﬁle
of the (4S-F)Pro congener had a totally different shape, which
seems to resemble a type I β-turn. However, for this congener a
two-state transition could not be detected by CD spectroscopy,
which was the case for the native protein and the (4R-F)Pro con-
gener. The related Tt values measured by CD spectroscopy (29
and 23 °C) were in agreement with the DSC experiments for the
two congeners. As NMR analysis identiﬁed the trans isomer as
the major conformation in all polypeptides, the cis/trans isomeri-
zation cannot explain the different assembly behavior. It is there-
fore more likely that the puckering of the pyrrolidine ring has a
direct inﬂuence on the overall structure. The authors claim that
due to stereoelectronic effects, the conformation of the (4R-F)
Pro might be pre-organized in a way that favors the type II
β-turn structure.128
The elastin-mimetic polypeptide has also been used for the
incorporation of (3R-F)Pro and (3S-F)Pro in order to study the
effect of ﬂuorination in position 3 of the pyrrolidine ring.126,131
Compared to their 4-ﬂuoro counterparts, these analogs exhibit an
Fig. 5 Schematic representation of the endo and exo pucker conformation of proline and its ﬂuorinated derivatives (A) as well as of the cis and trans
prolyl peptide bond (B).
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opposed pyrrolidine ring puckering as a consequence of the
gauche effect, supported by crystallographic analyses of model
compounds. The (3R-F)Pro displays an Cγ-exo puckering
whereas the (3S-F)Pro displays an Cγ-endo-puckering. Consider-
ations regarding the syn/anti orientation are of great interest
when comparing (3-F)Pro and (4-F)Pro analogs: (3R-F)Pro (exo)
has a syn arrangement in respect to the conﬁguration of the Cα,
while (4S-F)Pro has a syn orientation too but shows a Cγ-endo
puckering. The same is true for the anti-arrangements: (3S-F)Pro
exhibits an Cγ-endo puckering and (4R-F)Pro an Cγ-exo-pucker-
ing. The preferences of the analogs are transferred from the
small molecules to the related elastin-mimetic.128,131 The authors
succeeded in the expression of (3-F)Pro containing congeners
with high substitution efﬁciencies. Again, it could be shown that
an exo puckering of Cγ stabilizes type II β-turn structures at
increased temperatures whereas an endo puckering favours more
type I β-turn conformations.131 The transition point for the con-
formational rearrangement from a random coiled structure to
higher ordered β-turn motifs could be determined to be 30 °C
and 10 °C for elastin[(3R-F)Pro] and elastin[(3S-F)Pro], respec-
tively, by CD spectroscopy and differential scanning calorimetry.
This means, the syn-ﬂuoroprolines raise the transition temp-
erature of the related proteins.128,131 As for the (4-F)Pros, the
cis/trans isomerization equilibrium can be ruled out as the
reason for this observation, as NMR revealed that all 3-ﬂuoro-
prolines prefer the trans conformation.131,132
Steiner and co-workers proved that puckering also has a great
impact on the folding of the β-sheet-rich green ﬂuorescent
protein (GFP).27 The refolding rate of GFP, and its mutants, is
known to be relatively slow.133 This is often attributed to the cis/
trans isomerization of peptidyl-proline bonds discussed pre-
viously. Attempts to incorporate (4R-F)Pro into EGFP, a mutant
of GFP consisting of 10 Pro residues, led to the formation of
insoluble inclusion bodies. In contrast, substitution of all Pro
residues with (4S-F)Pro yielded in a soluble protein isolation
with enhanced (re)folding properties (e.g. faster refolding
kinetics). In addition, a higher ﬂuorescence recovery after de-
naturation could be achieved compared to the parent protein. Fur-
thermore, the (4S-F)Pro congener is less prone to aggregation.
All these ﬁndings could be mainly attributed to 12 new stabiliz-
ing interactions, as detected by X-ray analysis. These new inter-
actions involve the ﬂuorine atoms and the puckering of the
pyrrolidine ring. As nine out of ten (4S-F)Pro residues show
endo puckering, conformational preferences might lead to some
form of preorganization.
With regard to the capability of the incorporation of 4-ﬂuoro-
prolines into the thermophilic KlenTaq DNA polymerase,
Holzberger and Marx reported contrary observations compared
to the EGFP of Steiner et al.134 The polymerase consists of 32
Pro residues which were exchanged in high efﬁciency (92%) for
(4R-F)Pro. However, the authors noted a dramatic decrease in
protein yields. On the other hand, the (4R-F)Pro congener is as
active as the parent protein. The same holds true for ﬁdelity and
sensitivity. Conversely, the (4R-F)Pro congener displayed a
lower thermostability compared to the parent protein. In addition,
the authors failed to incorporate (4S-F)Pro.
The same holds true for the incorporation of (4-F)Pro residues
into human ubiquitin.135 Again, only the Pro → (4R-F)Pro sub-
stitution was successful (in yields comparable to the parent
protein) whereas (4S-F)Pro incorporation could not be detected.
This is reasonable, as the Pro residues of the 76 amino acid con-
taining protein favor the Cγ-exo puckering as (4R-F)Pro does. In
addition, the Pro residues exhibit trans conformation which is
also promoted by (4R-F)Pro. Fluorination proved again to be
beneﬁcial for the stability of the protein which retains its activity
(in in vitro analysis). The folding kinetics revealed a slightly
faster folding and a 2.6-fold slower unfolding (measured at
acidic pH). Furthermore, the secondary structure was not affected
by ﬂuorination as careful inspection of the CD proﬁles revealed,
but the melting temperature was higher for the congener. The
authors also performed computer simulations and found that
ﬂuorine is involved in several stabilizing interactions; e. g. with
amide groups of the backbone. All these interactions are only
possible with Cγ-exo puckering whereas Cγ-endo puckering
would generate repulsive interactions.
It seems TTL and the elastin-mimetic polypeptides are among
the few examples where incorporation of (4S-F)Pro or (4R-F)Pro
into the same protein can be afforded without decreased yields
for one of the congeners (vide supra).111,126 This could be
explained by the results of peptide studies showing that the
biased C4 ring puckering of proline due to stereoelectronic
effects cannot selectively stabilize or destabilize the structure
when the proline residue is involved in other interactions,
e. g. aromatic-proline interactions.116 On the other hand, the
ﬂexibility/structural rigidity of the biopolymer might be impor-
tant as well. Small peptidic antibiotics like lanthibiotics can be
also ribosomally synthesized with either (4S-F)Pro or (4R-F)Pro
in their sequence.136 In this context it is also worth to note
again, that in case of EGFP incorporation of one isomer ((4S-F)-
Pro) resulted in a soluble congener whereas incorporation of the
other one ((4R-F)Pro) led to the formation of insoluble protein
precipitate.27 In contrast, in KlenTaq DNA polymerase and
human ubiquitin no expression at all could be detected with the
disfavored isomer.134,135 Thus, not only folding but also biosyn-
thesis of proteins might be affected by the different stereo-
chemistry of the ﬂuorinated proline residue.
In summary, these ﬁndings clearly demonstrate that with
detailed structural information of a protein, the use of ﬂuorinated
NCAAs analogs allow for new strategies for the design of tailor-
made proteins with folding and stability characteristics superior
to those of the native molecules. In addition, stereoselective pre-
ferences for the isomers during translation is most probably due
to a preorganization effect in the structure of the target protein,
although other factors such as ribosomal translational editing
and proofreading and co-translational folding cannot be
excluded. Therefore, ﬂuorinated Pro-residues might be also seen
as a tool to study and understand the basic mechanisms of
protein translation.
Fluorinated autoﬂuorescent proteins
Green ﬂuorescent protein and its mutants and variants are attrac-
tive targets for studying the effects of non-canonical amino acid
incorporation.137 Of special interest are, for instance, the ﬂuori-
nation of the respective chromophores. For example, the
dynamics and spectroscopic characteristics upon ﬂuorotrypto-
phan ((4-F)Trp, (5-F)Trp or (6-F)Trp) incorporation into EGFP
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and ECFP (enhanced cyan ﬂuorescent protein) have been
studied.109,138 Whereas EGFP contains only a single Trp residue
in position 57, ECFP, in addition, harbors Trp66 as a part of the
chromophore. Interestingly, in 19F NMR analyses of the ﬂuori-
nated EGFP and ECFP congeners, two and four signals were
detectable, respectively, reﬂecting two states of each ﬂuorinated
Trp residue. Slow exchange processes are also indicated by
broad signals and could be further estimated to be in the time
frame of 1.2–1.4 ms. In addition, the population of the two states
is temperature dependent and differences in enthalpy and entropy
could be measured. Further analyses showed that dimerization
and aggregation can be excluded as reasons for the peak widen-
ing. Chromophore isomerization can also be ruled out139,140 as
well as different protonation states. As ECFP[(6-F)Trp] exhibits
two (6-F)Trp57 signals also in the denatured state, the authors
argue that the cis/trans isomerization of the Pro56-Trp57-Pro58
sequence might be responsible for this observation. In contrast,
the signal widening for the ﬂuorinated Trp66 in ECFP might
arise from changes in the surrounding of the chromophore. For
example, Tyr145 and His148 show an increased ﬂexibility indi-
cating some conformational freedom, and they are located in the
vicinity of Trp66.109,141 To date, the related two conformational
states of the proteins could only be detected in solution
(19F NMR) but not in crystal structures.138 As the ﬂuorescence
properties of these proteins arise mostly from the chromophore,
it was expected that the incorporation of ﬂuorotryptophans into
EGFP will have no signiﬁcant effect and indeed there is no
difference in the spectral proﬁles of the congeners and the parent
protein. Conversely, the absorption proﬁle of ECFP is slightly
affected by a blue-shift of 6 nm with the exception of ECFP-
[(6-F)Trp] where only a 2 nm blue-shift is detectable. The emis-
sion maxima are also blue-shifted in the range of 2–10 nm. Fur-
thermore, the relative ﬂuorescence is decreased by 30–60%. This
reduction correlates with the position dependence of halogenated
porphyrins.142
In order to study EGFP in more detail, it was equipped with
either (2-F)Tyr or (3-F)Tyr.95,96 Incorporation of these analogs
into EYFP was performed for comparison as well. The eleven
Tyr residues were replaced quantitatively and slight changes in
the spectral properties could be detected. In EGFP, incorporation
of (2-F)Tyr resulted in a 6 nm blue-shift in absorption and the
regioisomer (3-F)Tyr showed a blue-shift of only 3 nm whereas
the in the emission proﬁles either a blue-shift of 6 nm or a red-
shift of 4 nm was detectable.95 The relative ﬂuorescence intensi-
ties differed markedly when compared to the parent protein. For
EYFP, the situation is slightly different. Here, the two isomers
exhibited either a blue-shift of 10 nm ((2-F)Tyr) or a red-shift of
4 nm ((3-F)Tyr) in the absorbance spectra. Similar trends were
observed in the ﬂuorescence properties. Here, the blue-shift is
7 nm and the red-shift 6 nm. Interestingly, in EYFP the relative
ﬂuorescence intensity is either equal to or even slightly higher
than for the congeners. The differences between EGFP and
EYFP may result from the fact that in the latter protein not only
the chromophore itself is affected by ﬂuorination but also
Tyr203 in its vicinity (stacking position). Furthermore, it was
investigated if any changes can be observed by pKa shifts upon
ﬂuorination as the values differ for the free amino acids (Tyr:
pKa = 10.05, (3-F)Tyr: pKa = 8.5).
68 Indeed, pH titrations of the
chromophore revealed decreased values in the range from 0.1 to
1.2 units (Fig. 6). These experiments also showed that the
absorption spectra of EGFP and EYFP are strongly pH depen-
dent. However, this is less pronounced in the ﬂuorinated conge-
ners but EYFP[(2-F)Tyr] behaves similar to the parent protein at
low pH values.95
In addition, high-resolution crystallographic analysis was per-
formed on the congeners and revealed only marginal changes of
the overall folding. However, careful inspection of the data
revealed crystallographic distances between ﬂuorine atoms and
hydrogen donors allowing for weak interactions. In contrast to
(2-F)Tyr which exhibits only one conformation at all positions
and none of the ﬂuorine is involved in special interactions, some
of the (3-F)Tyr residues in EGFP[(3-F)Tyr] adopt two confor-
mations (Fig. 7). The authors assumed that in these cases ring
ﬂipping is connected to the position of the aromatic residue
(buried or solvent-exposed). For instance, (3-F)Tyr145 is
involved in several contacts with atoms of different residues in
its vicinity as well as water molecules and only one conformer is
detectable. In contrast, buried (3-F)Tyr92 and partially exposed
(3-F)Tyr143 adopt two conformations, with the latter not
involved in particular interactions. This could also be conﬁrmed
by the NMR studies of Khan and co-workers.108 They used a
truncated mutant of GFPuv and mutated each Tyr residue one
after the other to Phe in order to assign the NMR signals. From
their experiments they concluded that ring-ﬂipping must be a
slow process and is in a time frame of 160 s−1 for (3-F)Tyr143
and 960 s−1 for (3-F)Tyr92. As the other residues exhibit no or
only marginal ring ﬂipping conformers, the authors argue that
packing effects inﬂuence the ﬂexibility.
It is even more interesting that (3-F)Tyr in position 66 (as part
of the chromophore) exhibits two conformations as well; even
though its surrounding is rather rigid as judged from the B
factors.96 The phenolate oxygen of the chromophore is in
contact with residues in its vicinity and the chromophore itself
interacts via hydrophobic interactions with Val50 and Phe165.95
The two conformations are termed major and minor, respect-
ively, as they are occupied to 60 and 40%. In both cases, the
hydroxyl group of the (3-F)Tyr residue interacts with Thr203
and His148 through hydrogen bonding (in the major confor-
mation, ﬂuorine interacts with the Cγ of Thr203 which might be
a rather unusual example of a weak CF⋯CH interactions).95,96
Fig. 6 Inﬂuence of chromophore ﬂuorination on ﬂuorescence pH titra-
tion proﬁles in parent and congener EGFPs (left panel) and EYFPs
(right panel). Whereas there is almost no change in the pKa values for
most of the congeners EYFP[(3-F)Tyr] has a pKa value decreased by
1.2 units.
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The authors argued that ﬂipping of the chromophore does not
take place. It seems to be more plausible to assume that the two
states arise during chromophore maturation. In this context it is
worth to note, that the occurrence of only one conformer in
EGFP[(2-F)Tyr] must have arisen due to steric reasons, as
further analysis revealed that by adaption of the alternative con-
formation the ﬂuorine atom would directly clash with the ring
nitrogen of the chromophore. Additional studies demonstrated
that the ﬂuorination of the chromophore by introducing either
(2-F)Tyr or (3-F)Tyr has no effect on its photostability in EGFP
or EYFP.143
(3-F)Tyr was also used to study the effect of ﬂuorination on
the chromophore of DsRed.144 Again, it was argued that even if
all Tyrs were exchanged by the analog, only ﬂuorination of
Tyr67 will affect the ﬂuorescence properties as shown for GFP
mutants.95,96,141 The ﬂuorescence excitation spectra of the parent
protein and the congener showed no differences, except in the
intensities. The spectrum of the ﬂuoro-congener is more intense.
However, after excitation at 556 nm, the emission maximum of
the parent protein can be detected at 603 nm, whereas the
maximum of dsRed[(3-F)Tyr] is blue-shifted by 12 nm to
591 nm. This might be attributed to electron-withdrawing effects
since comparison with incorporated (3-NH2)Tyr revealed a red-
shift of 12 nm. Whereas the ﬂuoro-congener again showed
higher ﬂuorescence intensity when studied under the same con-
ditions as the parent protein, it has a lower extinction coefﬁcient
(59 000 compared to 47 000). However, its quantum yield is also
higher than the one of the dsRed itself (0.25 compared to 0.04).
Careful inspection of the UV/Vis spectra revealed that upon
ﬂuorination the spectral shoulder at 480 nm is more pronounced.
This absorption maximum is attributed to a green-emitting inter-
mediate of the chromophore. As the 480 nm absorption is even
higher as the 556 nm absorption in the ﬂuoro-congener, the
question arises whether ﬂuorination hinders a proper chromo-
phore formation.
Besides the efforts to incorporate aromatic non-canonical
amino acids, aliphatic analogs have also been tested. For
example, Tﬂ or Tfm have been incorporated into an EGFP
mutant containing only 2 Met residues (Fig. 8).145 However,
these ﬁrst trials resulted only in a very inefﬁcient substitution
and the low expression yields were attributed to the increased
size/van der Waals radius 20,146 of the triﬂuoromethyl group.
Despite the low yields, it was possible to analyze the Tfm con-
taining congener by 19F NMR and the detected signals could be
assigned. Problems during substitution experiments using Tﬂ
were faced as well by Tirrell and Yoo.147 Nevertheless, they suc-
ceeded in the evolution of a GFP carrying Tﬂ (vide infra).148
Taken together, global and site-directed ﬂuorinations of green
ﬂuorescent proteins enabled the design of congeners with novel
and unique biophysical properties including changes in titration
curves as well as variations in the absorbance and ﬂuorescence
proﬁles. The global ﬂuorination of autoﬂuorescent proteins to
the level of “atomic mutations” (i.e. H → F replacements) offer
Fig. 8 19F NMR analysis of the congener EGFP-2M[Tfm]. The differ-
ence in chemical shift and shape of the two signals assigned to the two
ﬂuorinated residues is due to the different chemical microenvironment of
the Tfm residues within the protein structure given rise to the assumption
that the congener is correctly folded.
Fig. 7 Survey of the conformation of exemplary Tyr residues in EGFP substituted by either (2-F)Tyr or (3-F)Tyr revealed by X-ray analysis. Note
that in the case of EGFP[(2-F)Tyr] all ﬂuorinated residues exhibit only one conformation whereas some of the (3-F)Tyr residues adopt two confor-
mations in the related congener. For further discussion see text.
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unprecedented opportunities to understand and manipulate the
relationship between protein structure and its spectroscopic
properties.
Towards ﬂuorous proteins149–protein design with
triﬂuoromethyl groups
As already mentioned, many studies have been performed using
non-canonical amino acids equipped with triﬂuoromethyl
groups. A very interesting result of these studies is the fact that
Hﬂ destabilizes α-helices but stabilizes β-sheets.13,150 Thus, the
structural framework of a model protein should be considered
when designing incorporation experiments. However, it is highly
desirable to investigate if it is possible to generate “Teﬂon pro-
teins”, regarding their potentials arising from the unique proper-
ties of ﬂuorine.149 Teﬂon itself is a ﬂuorous polymer and
according to Gladysz and Curran the term ﬂuorous means
“highly ﬂuorinated or ‘rich in ﬂuorine atoms’ and based upon
sp3-hybridized carbons”.151 Generally speaking, compounds in
which a large potion or even all hydrogen atoms are completely
replaced by ﬂuorine atoms, could be deﬁned as ﬂuorous. Further-
more, to generate real ﬂuorous or “Teﬂon” proteins techniques
are needed to synthesize biopolymers with multiple perﬂuori-
nated side chains which are sufﬁciently close in space to allow
interaction in the folded state. There are many potential beneﬁts
of Teﬂon proteins, e.g. they may ﬁnd industrial application due
to their predicted resistance to unfolding in organic solvents,
which has been summarized by Marsh.149
A ﬁrst step on the way to generate Teﬂon proteins is the global
introduction of triﬂuoromethyl groups into proteins. These works
are based on studies involving peptides and chemically syn-
thesized proteins as described in the ﬁrst part of this review. In
1963, Rennert and Anker were the ﬁrst ones using Tﬂ as
medium supplement and observed it’s in vivo incorporation into
E. coli proteins.41 In 1975, there was an indirect evidence for
Tfm incorporation into TCA-insoluble protein fractions from
S. cerevisiae.63
In 1997, the Honek lab reported the successful incorporation
of Tfm into bacteriophage λ lysozyme (LaL) consisting of three
Met residues.62 By careful control of the expression conditions,
the efﬁciency of incorporation could be modulated being either
high (70%) or low (30%). The resulting congeners were ana-
lyzed by mass spectrometry. Higher Tfm concentrations resulted
in lower overall protein yields and vice versa, and excessively
high concentrations seemed to be toxic for the cells. However,
the activity of the congeners was similar to the one of the parent
proteins. By 19F NMR analysis, four sharp signals could be
detected for the three Tfm residues which means that one residue
splits into two signals with their intensities being inﬂuenced by
the incorporation level. The authors provided a model for the
structural reason of the two signals representing one Tfm which
includes subtle changes in the protein structure by the incorpor-
ation of the ﬂuorinated analog. Later experiments revealed that,
in the M14L mutant of LAL, the set of double signals vanishes
and only one resonance per residue is detectable.152 Thus, signal
assignment could be performed. Furthermore, not only the size
of Tfm is increased compared to Met62,152 but also the hydro-
phobicity is altered by the 3 H → F substitutions. For instance,
the log P value for ethyl triﬂuoromethyl sulﬁde was calculated to
be 2.73 compared to 0.80 for ethyl methyl sulﬁde. This is also
reﬂected in the increased retention time of the LaL congener
with high substitution level on reversed-phase HPLC columns.
Even though the presence of maximal three triﬂuoromethyl
groups is insufﬁcient to make the LAL congener a ﬂuorous mo-
lecule, it has to be stated that the hydropathy is already greatly
affected. Similar observations have been made for the increased
hydrophilicity after the incorporation of a single azatryptophan
into a model protein.153 In addition, CNBr/formic acid reaction
of Tfm containing lysozyme yielded only non-digested protein at
Tfm positions.154 In addition to Tfm, diﬂuoromethionine (Dfm)
was incorporated into LAL and studied by 19F NMR.155 In con-
trast to Tfm, the Dfm congener was expressed in high yields and
high substitution efﬁciency (almost 100% according to ESI MS).
Again, the congener retained complete catalytic activity com-
pared to the parent protein. The observed 19F NMR signals
could also been assigned to the different Dfm positions.
Both amino acids, Dfm and Tfm, were also used as probes for
conformational changes in MetRS upon binding and in the ATP :
PPi exchange assay.
156,157 By doing this, they could identify key
residues of E. coli MetRS (e.g. Y15, W253, H301 and other aro-
matic amino acids). Dfm binding caused, in general, the same
conformational changes as Met although the enzyme afﬁnity was
slightly decreased. In case of Tfm, the conformational changes
were different compared to the native substrate. With this
ﬁnding, the authors explained the dramatically lowered Tfm
incorporation rate into proteins by the less efﬁcient tRNAMet
aminoacylation of Tfm. In another series of experiments, the
reduction potential of semisynthetic azurin could be tuned by the
incorporation of Dfm or Tfm into the protein at position 121.158
Following this logic of thinking, Garner and co-workers saw an
indication for a linear correlation between the reduction potential
and the hydrophobicity. According to them, this is also true for
other type 1 copper-containing proteins regardless of their scaf-
fold or the general experimental set-up.
More recent attempts to incorporate Tfm into an EGFP mutant
consisting of only two Met residues resulted in only poor substi-
tution efﬁciencies.145 During spectral characterization, no
shoulders or shifts were detectable in the spectra giving rise to
the assumption that Tfm does not affect the spectral features of
the protein. The expression yielded enough protein to perform
NMR studies and peak assignment (Fig. 5). Furthermore, the
experiment indicated an effective blockage of the N-terminal
methionine excision by Tfm. In further experiments, the incor-
poration of Tﬂ into anxA5, b*, GFP and mini-IGFBP was
carried out. Again, only marginal incorporation could be
detected in all these model proteins. However, TTL served as a
suitable model protein for the incorporation of Dfm which could
be incorporated with a good efﬁciency. Tfm, again, was incor-
porated only less efﬁcient (unpublished work of the authors).
Both congeners had a lower optimal temperature (60 °C com-
pared to 70 °C of the parent protein) and were in general less
active. In addition, unpublished data of the authors revealed an
incorporation efﬁciency of approx. 60% of Tfm into anxA5.
This was achieved by the co-expression of E. coli MetRS.
Very recently, the lab of Marx reported the successful incor-
poration of Tfm into a DNA polymerase, namely the N-termin-
ally truncated KlenTaq DNA polymerase I of Thermus
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 7241–7261 | 7255
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aquaticus.159 This mutant consists of 540 amino acids of which
14 are Met residues including the N-terminal one. The efﬁciency
of incorporation was 82%. The congener was an active enzyme
with selectivity comparable to the parent protein. However, the
activity was only one third of the parent protein and the congener
also lost thermal stability. Furthermore, in contrast to a related
(4R-F)Pro congener (vide supra) the Tfm congener was only
active in high concentrations or in the presence of high substrate
concentrations. Interestingly, in the 19F NMR analysis only 9
signals were detectable but the authors could observe confor-
mational changes after DNA template and subsequent ddCPT
addition, respectively, by detecting shifts of the resonances.
Another non-canonical amino acid attracting the attention of
researchers is Tﬂ. For example, Tang and co-workers reported its
in vivo incorporation into leucine zipper protein A1.160 The 73
amino acid containing model protein consists of 8 Leu residues
which were replaced by Tﬂ with an efﬁciency of 92%. The yield
of the congener was only 50% of that of the parent protein
(whereas lower incorporation levels yielded more isolated
protein, but attempts to incorporate Hﬂ failed completely, vide
infra). Although the electrophoretic mobility increased, the CD
proﬁles of parent protein and congeners remained almost identi-
cal and indicated a high helical content (90%). Substituting the
d-positions of the leucine zipper with other canonical amino
acids resulted in a reduction of the coiled-coil stability. In con-
trast, the ﬂuorinated congeners showed a higher resistance to
thermal denaturation, reﬂected in melting temperatures up to
13 K higher compared to the parent protein. The same holds true
for the chemical denaturation where the midpoint concentration
of urea increased from 2.8 M up to 7 M in case of the high-level
ﬂuorinated protein. It should be noted, that already less substi-
tuted proteins show the same trends of increased stability. For
peptides synthesized in vitro, Kumar and co-workers observed
similar trends.15 In contrast, the introduction of Tﬂ into the
chloramphenicol acetyltransferase (CAT) led to a decreased ther-
mostability as well as chemostability (vide supra).110 Since ﬂuor-
ination resulted in a more highly ordered protein as judged by
CD spectroscopy, it can be taken as indication that better struc-
tured biopolymers do not have to be automatically more stable.
In order to tackle the problem of the decreased stability of CAT
[Tﬂ], Montclare and Tirrell combined non-canonical amino acid
incorporation and directed evolution.161 Their evolutionary
approach was set up to overcome the 20-fold reduction in t1/2 of
thermal inactivation at 60 °C. Already after two rounds of
random mutagenesis and screening they were able to identify
three mutations compensating the loss in thermostability caused
by ﬂuorination. A similar approach was used for the incorpor-
ation of Tﬂ into a GFP mutant as mentioned above.148 Here, the
substitution of 78% of the Leu residues led to a vanishing of the
protein’s ﬂuorescence as the protein was not correctly folded.
After 11 rounds of evolution the incorporation efﬁciency could
be increased to 87% and – even more importantly – the ﬂuor-
escence could be restored. In addition, the refolding rate after
acid denaturation was enhanced by the evolution.
The Tﬂ constitution isomer 5-triﬂuoroisoleucine (5-Tﬁ, (5-
CF3)Ile) has been successfully used for incorporation exper-
iments, for instance into murine dihydrofolate reductase
(mDHFR) and a cytokine murin interleukin-2 (mIL-2) consisting
of 14 and 5 Ile residues, respectively.162 The level of
incorporation was appreciably high (93 and 85%), which is sur-
prising as the speciﬁc constant for the activation of 5-Tﬁ by the
E. coli isoleucyl-tRNA synthetase is two orders of magnitude
lower than for isoleucine. The congener of mIL-2 was further
investigated and it turned out that the concentration for 50% of
the maximal proliferative response is increased by approx. 30%
compared to the parent protein. Any attempt to incorporate
3-triﬂuoroisoleucine (3-Tﬁ, (3-CF3)Ile) failed. In contrast, incor-
poration of 6-triﬂuoronorleucine (Tfn, (6-F3)Nle) could be per-
formed after circumventing some restrictions. Tfn itself does not
support protein biosynthesis in E. coli. On the other hand, nor-
leucine (Nle) is one of the most effective Met substituents
known to date. In order to detect Tfn incorporation Yoo and
Tirrell had to engineer E. coli’s MetRS by saturation mutagenesis
with a GFP mutant as reporter protein.147 By a combined posi-
tive and negative screening, they were able to identify a mutant
capable of activating Tfn. Subsequently, Tfn was incorporated in
very high efﬁciencies into different model proteins even if the
speciﬁc rate constant (kcat/km) of the mutated MetRS was seven-
fold lower for Tfn compared to Met. This approach was also suc-
cessfully transferred and applied to analogs without ﬂuorine
atoms.163
The successful incorporation of Hﬂ into leucine zipper protein
A1 could be performed using a modiﬁed leucyl-tRNA synthetase
of the host (E. coli).164 The yield decreased to a ﬁfth of the
parent protein, but in the light of the related in vitro activation
data this is reasonable. In the related assays it turned out that
activation of Hﬂ is 4000-fold lower compared to leucine,
whereas Tﬂ activation is only 242-fold lower. However, by over-
expression of E. coli LeuRS 74% of all Leu residues could be
replaced by Hﬂ. The resulting coiled-coil protein proved to be
more stable compared to the one with incorporated Tﬂ in
thermal denaturation analysis (Tm,Leu = 54 °C, Tm,Tﬂ = 67 °C,
Tm,Hﬂ = 76 °C). In addition, even in 8 M urea there is no com-
plete unfolding of the biopolymer. The question arises again if
this is due to a kind of ﬂuorous effect or due to the increased
hydrophobic character of the triﬂuoromethyl groups in the pro-
tein’s core. Furthermore, only a minimal disruption of the
folding and assembly of the coiled-coil architecture of the Hﬂ
congener could be detected in comparison to the parent protein.
The results obtained in these experiments are in accordance with
related peptide studies.12,14,165
Interestingly, the ﬁrst attempts to incorporate the two epimers
of 4,4,4-triﬂuorovaline ((3-CF3)Val) were unsuccessful.
166 Sub-
sequent in vitro activation analyses revealed that the (3S-CF3)Val
epimer is not activated by ValRS or IleRS, but (3R-CF3)Val is
activated by both enzymes. However, the speciﬁcity constant is
strongly decreased. The rate of activation is 600- (IleRS) and
2500-fold (ValRS) reduced compared to the natural substrates.
Nonetheless, the authors could successfully incorporate (3R-
CF3)Val in vivo into mDHFR by the co-expression of IleRS or
ValRS. In this way, 92% of all Ile residues or 86% of all Val
residues could be substituted by (3R-CF3)Val. This is the ﬁrst
striking example of two different canonical amino acids being
exchanged by a single ﬂuorinated amino acid.
Whereas the results mentioned above have been gained by
supplementation based procedures, stop codon suppression
methods can also be used for the incorporation of ﬂuorinated
amino acids as described above. Despite the fact that (2,3,5,6-
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F4,4-CH3)Phe does not fulﬁll the deﬁnition of a ﬂuorous mo-
lecule as introduced above (since it is an aromatic amino acid) it
should be mentioned here.86 Furthermore, (4-CF3)Phe
75 is an
aromatic acid bearing an aliphatic triﬂuoromethyl group, which
is now widely used as probe in 19F NMR analysis (vide
supra).80 Another example for the successful introduction of a
CF3 group by the SCS approach is the pyrrolysine derivative
Nε-triﬂuoroacetyl-L-lysine, which can be incorporated into target
proteins in S. cerevisiae.98
It is obvious that the major deterrent for triﬂuoroleucine and
hexaﬂuoroleucine incorporation in larger proteins is their steric
bulkiness and, thus, their difﬁcult accommodation in the folded
protein interior. Therefore, future studies will certainly face quite
challenging questions such as: (i) which factors play crucial
roles in the translation of triﬂuorinated amino acids; (ii) to which
extent native proteins can be substituted with tri- and hexaﬂuori-
nated amino acids (triﬂuoroleucine, triﬂuorovaline, and their
hexaﬂuoro counterparts, triﬂuoromethionine and triﬂuoronorleu-
cine etc.); (iii) to which extent perﬂuorinated amino acids (all
hydrogens substituted by ﬂuorine) can be introduced to proteins;
(iv) what can be learned about protein folding and the possibili-
ties for rational protein design (retaining structure and function
of native proteins) with such substances; and ﬁnally (v) whether
it is possible to perform the de novo design of proteins exhibiting
a ‘ﬂuorous effect’.
Multiple incorporation of different ﬂuorinated amino acids
Whereas the incorporation of non-canonical amino acids with
more than one ﬂuorine atom is a ﬁrst step in the direction of
Teﬂon proteins, another one is the incorporation of different
amino acid analogs at the same time.167 Here, stop codon sup-
pression methods and orthogonal ribosomes are quite restricted,
e.g. because of the difﬁculties with more than one in-frame stop
codon having to be suppressed and the competition between
release factors and suppressor tRNAs. The auxotrophy-based
approach offers a much simpler and more effective experimental
set-up. In the ﬁrst proof-of-principle experiment it was demon-
strated by Lepthien and co-workers that three amino acids can be
substituted in vivo in a single expression experiment.28 In this
way, barstar (10 kDa) could be equipped with a reactive handle
(homopropargylglycine), a ﬂuorescent tag (4-azatryptophan) and
a stabilizing non-canonical amino acid ((4S-F)Pro). This
approach was further investigated by the triple incorporation of
three monoﬂuorinated amino acids into the lipase of Thermo-
anaerobacter thermohydrosulfuricus.29 The amino acids of
choice were (4S-F)Pro, (4-F)Phe and (6-F)Trp to substitute Pro,
Phe and Trp. The His-tagged protein consists of 267 amino acid
of which 6 are Pro, 16 Phe and 2 Trp. This means, 10% of the
protein has been ﬂuorinated. The species with all 24 residues
substituted was the dominant signal in the ESI MS spectrum but
also species with only 23 and 22 ﬂuorine atoms were detectable.
The overall yield was approx. one fourth of that of the parent
protein. MS/MS analysis of the tryptic fragments revealed a
uniform distribution of ﬂuorine through the whole protein.
Regarding the spectral features of the protein, the characteristic
“ﬂuorophenyl-ﬁngers” of (4-F)Phe72 could be detected by UV/
Vis spectroscopy whereas the ﬂuorescence emission spectrum is
only slightly affected by ﬂuorination. This is, again, in accord-
ance with the literature.64 As revealed by CD spectroscopy, the
effects on secondary structure upon ﬂuorination were only mar-
ginal. The most prominent differences between parent protein
and congener were observed in the catalytic activity which is
decreased by approx. 40%. In addition, the congener has a
decreased optimal temperature (60 °C instead of 70 °C) which
corresponds to the values obtained for Dfm and Tfm incorpor-
ation. Also four amino acids could be substituted at the same
time. In this experiment, (4S-F)Pro, (2-F)Phe or (3-F)Phe, (4-F)-
Trp and (2-F)Tyr were incorporated into TTL (Fig. 9). Again, a
Fig. 9 Parallel incorporation of various ﬂuorine-containing amino acid analogs in a single fermentation experiment. Left: Predicted structure of the
TTL111 with highlighted canonical residues substituted by their monoﬂuorinated analogs (black: Pro → (4S-F)Pro, red: Trp → (4-F)Trp, magenta: Phe
→ (2-F)Phe or (3-F)Phe, blue: Tyr → (2-F)Tyr). Congeners with either triple or quadruple residue-speciﬁc substitution were generated. Middle: Fluor-
escence emission proﬁles of the parent protein and the congeners with four different ﬂuorinated amino acids. As expected, the congeners show almost
no ﬂuorescence activity due to the incorporation of (4-F)Trp.59 Right: Results of the activity assay studying the parent protein as well as the triple and
quadruple congeners. The most striking observation is the correlation of the ﬂuorine position in ﬂuorinated Phe with the activities of the related conge-
ners. Whereas (2-F)Phe bearing proteins are almost not active the congeners harboring (3-F)Phe are approx. 60% as active as the parent protein regard-
less if three or four types of canonical amino acids are substituted.
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very high substitution level could be reached. Most interestingly,
the regioisomers of ﬂuorophenylalanine have different effects on
the catalytic activity of the enzyme. Triple and quadruple conge-
ners containing (3-F)Phe again have a Topt of 60 °C and an
overall activity lowered by approx. 40% compared to the parent
protein. In contrast, the (2-F)Phe congeners display very little
activity. Thus, we are far away from understanding all the details
related to the incorporation of ﬂuorine into enzymes and under-
standing the resulting effects.
Making ﬂuorine an element of life: what is there to do?
The use of ﬂuorinated amino acids in protein engineering
yielded the development of several valuable tools, for example
in spectroscopy (NMR analysis of proteins, ﬂuorescence etc.)
and for the identiﬁcation of residues important for the catalytic
activity of enzymes. But ﬂuorine containing amino acids were
also used to study the intracellular accumulation of non-canoni-
cal molecules.42,168 Nonetheless, we are still far away from fun-
damentally understanding the effects of ﬂuorinated amino acid
analogs on the structural context and the catalytic performance
of proteins and enzymes. So far, it is not possible to predict the
effect of an H → F substitution in a protein. For instance,
whereas some proteins are stabilized by the introduction of
(4S-F)Pro, others are destabilized. On the other hand, the regio-
isomers of ﬂuorotyrosine and ﬂuorophenylalanine affect different
enzymes in a different manner. Thus, more research is indeed
needed to obtain novel data and extend existing knowledge in
order to gain a much more general view on the effects of carbon-
bond ﬂuorine in complex biological systems. There should be no
doubt that an investigation of the correlation between structural
context, incorporation/translation efﬁciency and catalytic activity
will be beneﬁcial, especially in biocatalyst development. Along
these lines, preliminary statements can be made regarding the
incorporation of ﬂuoroprolines and the dependence of favored
cis or trans peptidyl prolyl bonds in the parent protein. Our
group was among the ﬁrst reporting a systematic study on the
sensitivity of the translation machinery for chemical and chiral
isosteric (isostructural), proline analogs that are incorporated into
various proteins.27,111 In particular, we and others 126,131 have
discovered the stereochemical bias for the protein folding with
ﬂuoroprolines which is directly related to Pro puckering confor-
mation. We are currently performing detailed examinations with
various protein sequences in order to elucidate a mechanistic
basis for the plasticity of the ribosome for ﬂuorinated substrates.
Finally, the question ‘How far can we go?’ remains un-
answered. How much ﬂuorination would be tolerated in complex
systems such as proteins? In order to tackle this problem some
fundamental aspects of ﬂuorocarbons should be taken into con-
sideration. First, the source of the enhanced stability (measured
as increased resistance against chemical or thermal unfolding) is
not necessarily arising from favorable ﬂuorocarbon–ﬂuorocarbon
interaction(s) or enhanced hydrophobicity. Marsh and associates
argue that it could be “adequately explained by the increases in
buried hydrophobic surface area and volume that accompany
ﬂuorination”.171 Namely, if we consider ﬂuorous interactions as
favorable van der Waals-type interactions between ﬂuorocarbon
residues, the question is how strong are these interactions in the
context of the complex protein structure? Taking into account
that hydrocarbons are more polarizable than ﬂuorocarbons (since
the cohesive dispersion forces between two hydrocarbon mo-
lecules are greater than between two ﬂuorocarbons) it should not
surprising that we still lack solid evidence for this; e.g. self-seg-
regating properties of per-ﬂuorocarbon-containing proteins.
Taking all these considerations into account, one can ask: Is it
the biosynthesis of “Teﬂon-proteins” a realistic prospect? Given
the case that living beings never adopted ﬂuorine as biogenic
element, its accommodation into the protoplasmic chemistry is
indeed a formidable challenge. Living organisms would have to
be able to survive adaption on ﬂuorine through massive modiﬁ-
cations of their enzymes and proteins that are originally evolved
on hydrocarbon basis.24 This certainly requires the rewriting of
their entire genomic text by the accumulation of different types
of mutations and their combinations. Also evolution of the
sequence composition of the proteins of interest will be most
probably always required to some extent (as performed by Tirrell
and co-workers for the Tﬂ harboring GFP mutant). Therefore,
we believe that the design of artiﬁcial cells with ﬂuorine chem-
istry is a very challenging but achievable goal. On the other
hand, if this problem is insurmountable, we need to ﬁnd out
why.
In combination with the works mentioned in this review, the
experimental work on microbial cell evolution may lead to cells
whose proteome would consist of a novel chemical composition
and, thus, being real novel synthetic life forms. In this context it
is worth to take a look to the related ﬁeld of chemical modiﬁ-
cation of genomes. Only very recently, Marlière and co-workers
succeeded in the incorporation of 5-chlorouracil instead of
thymine into a genome.169 The E. coli strain whose progeny
retained the ability to use 5-chlorouracil is the ﬁrst in vivo proof
of a canonical–non-canonical border crossing in the ﬁeld of
nucleic acid research. This success in halogenation of a genome
implies the question whether halogenation, i.e. ﬂuorination, of a
proteome is possible. Would it be possible to design cells that
tolerate widely ﬂuorinated proteomes? Would this interfere with
the catalytic activity of too many enzymes? What about general
metabolic protein turnover and basic metabolism in the presence
of ﬂuorine?
There is already solid evidence in the literature that the pro-
teome-wide introduction of ﬂuorine could be possible. Till now,
SeMet is the only amino acid which can be incorporated into the
whole proteome (as proved by Cowie and Cohen26), but several
attempts have been reported to increase the number of proteome-
wide incorporated amino acids. One of the most important
experiments was reported in 1983 by Wong, who selected for
microorganisms capable of changing the intrinsic preference for
amino acids.56 He started his experimental evolution with the
Trp auxotrophic Bacillus subtilis strain QB928 which was seri-
ally mutated and cultured for many generations under deﬁned
conditions with a medium containing (4-F)Trp. Finally, he could
demonstrate that the mutant strain prefers (4-F)Trp over canoni-
cal Trp. This microorganism was described as a “ﬁrst free living
organism in the past couple of billion years to have learnt to
thrive on a genetic code that departs from the universal code”.56
The ratio behind the choice of (4-F)Trp as non-canonical amino
acid was the fact that natural TrpRS cannot distinguish between
Trp and the derivative since they have almost the same afﬁnity
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for this enzyme in activation and aminoacylation reactions.
Later, Ellington and Bacher reported two experiments in Wong’s
tradition in order to generate “unnatural organisms”.57,58 Their
ﬁrst report deals with the evolution of E. coli strains which
would be capable for surviving in (4-F)Trp containing medium.
They assumed that only a few proteins will be adversely affected,
and that mutation can circumvent these problems. Following this
line, (4-F)Trp should be inserted into the proteome. However,
the resulting strains retained a requirement for Trp, even if the
required concentration was very low. Thus, they concluded that
further re-optimization of proteins and metabolic pathways are
necessary in order to accommodate only (4-F)Trp instead of Trp.
For their next experiments, they switched to the bacteriophage
Qβ as the model system. Its replication was performed in an
E. coli strain with Trp auxotrophy. Again, the medium contained
different monoﬂuorinated Trp analogs. But as before, Qβ
retained an absolute requirement for traces of Trp. Thus, the
question arises how to select an organism by nutrient pressure
that becomes dependent on a non-canonical amino acid. The
very recent work of Wong who extended his examinations on
ﬂuorinated Trp analogs gives at least one possible answer.170
Finally it should be also mentioned that living beings are
indeed capable of developing enzymes for a carbon–ﬂuorine
bond formation.7 This ﬁnding indicates that metabolic engineer-
ing with organic ﬂuorine should be conceivable as well. In a
long term perspective, it might be possible to couple newly
designed ﬂuorine-related metabolic pathways with repro-
grammed protein translation or other processes (e.g. synthesis of
biological membranes or signal transduction pathways). The
synergy of these attempts and the experimental work on strain
evolution and protein engineering may lead to cells whose pro-
teomes consist of a novel chemical composition and, thus, being
real novel synthetic life forms.
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